Hollister Co., often advertised as Hollister or HCo., is a global teen and young adult retail brand owned by Abercrombie & Fitch Co. Goods are available in-store and through the company's online store. In 2019, Piper Jaffray ranked it in the top five clothing brands among teenagers.
Drug counterfeiting has been a major problem for the government and regulatory agencies since the beginning of the 20th century. Most of the drug counterfeiting reported is in countries where a high demand for drugs combines with poor surveillance, quality control, regulation, and education to make it easy for criminals and cartels to supply it to the market through illegal sources. These fake medications are frequently produced in hazardous conditions, with insufficient, excess, or no active ingredients, and/or by using potentially harmful and even fatal chemicals. Counterfeit drugs mostly affect vulnerable sections of society due to their social and economic conditions. Some critical factors, such as insufficient or no health insurance coverage, disparities with racial and ethnic minorities, government policies, low income, lack of education, and uncontrolled online pharmacies, tend to attract them towards counterfeit drugs. This article explains the key risk factors of counterfeit drugs operating in legal environments and reviews recent adverse cases in the pharmaceutical supply chain.
Background: Nursing practice should be evidence-based. As such, nurses should be able to rank sources according to a hierarchy of evidence and critically appraise the validity of studies. This is especially important in stoma care, where high-quality evidence is limited. Methods: Evidence appraisal is made easier by tools, such as the Critical Appraisal Skills Programme (CASP) for Randomised Controlled Trials (RCT). CASP was used to critique the ADVOCATE Trial, ( Colwell et al 2018 ), A Randomised Controlled Trial Determining Variance in Ostomy Skin Condition and the Economic Impact (ADVOCATE Trial), which had an adaptive design and compared the cost efficiency and efficacy of a ceramide-infused two-piece skin barrier with a comparator. The participants were randomised, and the trial was double blinded. Results: The trial addressed clearly focused issues. The improvement in cost efficacy for the trial group was statistically significant (p=0.017); in addition, three of six tertiary objectives were also statistically significant. Improvement in peristomal skin health was noticeable but not statistically significant. The results can be applied to other ostomy patient populations, and all clinically important outcomes were considered. Conclusion: CASP provided a staged and structured approach to review an RCT. It can help specialist nurses to find and apply relevant study findings to practice. CASP assessment found the ADVOCATE trial to be a reliable evidence base on which stoma care nurse could adjust their practice to optimise costs and peristomal skin health.
JADA welcomes letters from readers on articles that have appeared in The Journal. The Journal reserves the right to edit all communications and requires that all letters be signed. Letters must be no more than 550 words and must cite no more than five references. No illustrations will be accepted. A letter concerning a recent JADA article will have the best chance of acceptance if it is received within two months of the article's publication. For instance, a letter about an article that appeared in April JADA usually will be considered for acceptance only until the end of June. You may submit your letter via e-mail to “jadaletters@ada.org”; by fax to 1-312-440-3538; or by mail to 211 E. Chicago Ave., Chicago, Ill. 60611-2678. By sending a letter to the editor, the author acknowledges and agrees that the letter and all rights of the author in the letter sent become the property of The Journal. Letter writers are asked to disclose any personal or professional affiliations or conflicts of interest that readers may wish to take into consideration in assessing their stated opinions. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of the Association. Brevity is appreciated.